Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid

Chinese Journal of Physiology

Volumn 51, Issue 6, 2008, Pages 348-356

  Yu, Xiao Ning ^a   Chen, Xue Liang ^a   Li, Hao ^a   Li, Xiang Xin ^a   Li, Hui Qing ^b   Jin, Wen Rui ^c  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Carnosic acid; Multidrug resistance; P glycoprotein; Reverse

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CARNOSIC ACID; DOXORUBICIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; CELL LINE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; DRUG SENSITIVITY; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMIQUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84867262813     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barrand, M.A., Rhodes, T., Center M.S. and Twentyman, P.R. Chemosensitisation and drug accumulation effects of cyclosporine A, PSC 833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from Pglycoprotein. Eur. J. Cancer 29: 408-415, 1993.
2. 2+ ] signals from calcium-indicator dyes. News Physiol. Sci. 15: 19-26, 2000.
3. Chen, L., Xu, X.P., Wang, J.M., Fei, X.H., Gao, L., Zhou, H. and Huang, Z.X. Reversal of multidrug resistance in leukemia cell line by cyclosporin a combining with tamoxifen and interferon-α. J. Leukemia Lymphoma 12: 135-138, 2003.
4. Danilenko, M., Wang, Q., Wang, X., Levy, J., Sharoni, Y. and Studzinski, G.P. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1α,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium. Cancer Res. 63: 1325-1332, 2003.
5. Danilenko, M., Wang, X. and Studzinski G.P. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J. Natl. Cancer Inst. 93: 1224-1233, 2001.
6. Ferlini, C., Distefano, M., Pignatelli, F., Lin, S., Riva, A., Bombardelli, E., Mancuso, S., Ojima, I. and Scambia, G. Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors. Brit. J. Cancer 83: 1762-1768, 2000.
7. Fong, W.F., Wan, C.K., Zhu, G.Y., Chattopadhyay, A., Dey, S., Zhao, Z. and Shen, X.L. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes. Planta Med. 73: 212-220, 2007.
8. Ford, J.M. and Hait, W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42: 155-199, 1990.
9. Ford, J.M. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur. J. Cancer 32: 991-1001, 1996.
10. Gao, F., Wang, T., Sheng, M., Chen, B., Zhou, Y., Dong, Y., Cheng, J. and Zhang, P. Reversal effect of tetrandrine in combination with droloxifene on cell line K562/A02 and the correlation with apoptosis induction. Zhonghua Xue Ye Xue Za Zhi 12: 321-323, 2002.
11. Gong, Y.P., Liu, T., Jia, Y.Q., Qin, L., Deng, C.Q. and Yang, R.Y. Comparison of P-gp and MRP-mediated multidrug resistance in leukemia cell lines. Int. J. Hematol. 75: 154-160, 2002.
12. Gong, Y.P., Wang, Y.T., Chen, F.Y., Han, J.Y., Shao N.X. and Ouyang R.R. Subcellular distribution of daunorubicin in the Pglycoprotein-mediated multidrug-resistant cell line K562/ADR. Chinese J. Oncol. 23: 184-186, 2001.
13. Gong, Y.P., Wang, Y.T., Chen, F.Y., Han, J.Y., Shao, N.X., Fang, Z.W. and Ouyang, R.R. Altered subcellular distribution of daunorubicin in the non-P-glycoprotein-mediated multidrug-resistant cell line HL-60/ADR. Zhonghua Xue Ye Xue Za Zhi 21: 309-311, 2002.
14. Hurwitz, S.J., Terashima, M., Mizunuma, N. and Slapak, C.A. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. Blood 89: 3745-3754, 1997.
15. Inaba, M., Fujikura, R., Tsukagoshi, S. and Sakurai, Y. Restored in vitro sensitivity of adriamycin-and vincristine-resistant P388 leukemia with reserpine. Biochem. Pharmacol. 30: 2191-2194, 1981.
16. Larsen, A.K., Escargueil, A.E. and Skladanowski, A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther. 85: 217-229, 2000.
17. Lee, J.J., Jin, Y.R., Lee, J.H., Yu, J.Y., Han, X.H., Oh, K.W., Hong, J.T., Kim, T.J. and Yun, Y.P. Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis. Planta Med. 73: 121-127, 2007.
18. Li, H., Chen, X.L., Li, D.Q., Zhao, C.L., Feng, J.B. and Zhang, T. The influence of arsenic trioxide to HL-60 associated with CA. Zhonghua XueYe Xue Za Zhi 27: 194-197, 2006.
19. Ling V. P-glycoprotein and resistance to anticancer drugs. Cancer 69: 2693-2609, 1992.
20. Lo, A.H., Liang, Y.C., Lin-Shiau, S.Y., Ho, C.T. and Lin, J.K. Carnosol, an antioxidant in rosemary, suppressed inducible nitric oxide synthase through downregulating nuclear factor-κB in mouse macrophages. Carcinogenesis 23: 983-991, 2002.
21. Luan, F.J. Establishment of the multidrug-resistant cell line K562/ A02 and its drug-resistant properties. Zhonghua Zhong Liu Za Zhi 15: 101-103, 1993.
22. Marks, D.C., Bebov, L., Davey, M.W., Davey, R.A. and Kidman, A.D. The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leuk. Res. 10: 1165-1173, 1992.
23. Moriai, R., Asanuma, K., Kobayashi, D., Yajima, T., Yagihashi, A. and Yamada, M. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res. 21: 596-600, 2001.
24. Moreno, S., Scheyer, T., Romano, C.S. and Vojnov, A.A. Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic. Res. 40: 223-231, 2006.
25. Offord, E.A., Mace, K., Ruffieux, C., Malnoe, A. and Pfeifer, A.M. Rosemary components inhibit benzo(a)pyrene-induced genotoxicity in human bronchial cells. Carcinogenesis 16: 2057-2062, 1995.
26. Oluwatuyi, M., Kaatz, G.W. and Gibbons, S. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 65: 3249-3254, 2004.
27. Pusztai, L., Wagner, P., Ibrahim, N., Rivera, E., Theriault, R., Booser, D., Symmans, F.W., Wong, F., Blumenschein, G., Fleming, D.R., Rouzier, R., Boniface, G. and Hortobagyi, G.N. Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma. Cancer 104: 682-691, 2005.
28. Sandler, A., Gordon, M., De Alwis, D.P., Pouliquen, I., Green, L., Marder, P., Chaudhary, A., Fife, K., Battiato, L., Sweeney, C., Jordan, C., Burgess, M. and Slapak, C.A. A phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979) administered intravenously in combination with doxorubicin in patients with advanced malignancy. Clin. Cancer Res. 10: 3265-3272, 2004.
29. Sharabani, H., Izumchenko, E., Wang, Q., Kreinin, R., Steiner, M. and Barvish, Z. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int. J. Cancer 118: 3012-3021, 2006.
30. Stewart, A., Steiner, J., Mellows, G., Laguda, B., Norris, D. and Bevan, P. Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration. Clin. Cancer Res. 6: 4186-4191, 2000.
31. Visanji, J.M., Thompson, D.G. and Padfield, P.J. Induction of G2/ M phase cell cycle arrest by carnosol and CA is associated with alteration of cyclin A and cyclin B1 levels. Cancer Lett. 237: 130-136, 2006.
32. Wan, C.K., Zhu, G.Y., Shen, X.L., Chattopadhyay, A., Dey, S. and Fong, W.F. Gomisin A alters substrate interaction and reverses Pglycoproteinmediated multidrug resistance in HepG2-DR cells. Biochem. Pharmacol. 72: 824-837, 2006.
33. Wang, Q., Salman, H., Danilenko, M. and Studzinski, G.P. Cooperation between antioxidants and 1,25-dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/ AP-1/Egr-1 pathway. J. Cell Physiol. 204: 964-974, 2005.
34. Willingham, M.C., Richert, N.D., Cornwell, M.M., Tsuruoo, T., Hamada, H., Gottesman, M.M. and Pastan, I.H. Immunocytochemical localization of P170 at the plasma membrane of multidrugresistant human cells. J. Histochem. Cytochem. 35: 1451-1456, 1987.
35. Wuchter, C., Leonid, K., Ruppert, V., Schrappe, M., Buchner, T., Schoch, C., Haferlach, T., Harbott, J., Ratei, R., Dorken, B. and Ludwig, W.D. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Haematologica 85: 711-721, 2000.
36. Yang, J.Y., Luo, H.Y., Lin, Q.Y., Liu, Z.M., Yan, L.N., Lin, P., Zhang, J. and Lei, S. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R. World J. Gastroenterol. 8: 644-649, 2002.